IL162492A0 - Use of alkylphosphocholines for the preventative treatment of protozoandiseases - Google Patents

Use of alkylphosphocholines for the preventative treatment of protozoandiseases

Info

Publication number
IL162492A0
IL162492A0 IL16249203A IL16249203A IL162492A0 IL 162492 A0 IL162492 A0 IL 162492A0 IL 16249203 A IL16249203 A IL 16249203A IL 16249203 A IL16249203 A IL 16249203A IL 162492 A0 IL162492 A0 IL 162492A0
Authority
IL
Israel
Prior art keywords
protozoandiseases
alkylphosphocholines
preventative treatment
preventative
treatment
Prior art date
Application number
IL16249203A
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of IL162492A0 publication Critical patent/IL162492A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16249203A 2002-01-25 2003-01-07 Use of alkylphosphocholines for the preventative treatment of protozoandiseases IL162492A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10203195A DE10203195A1 (en) 2002-01-25 2002-01-25 Use of alkylphosphocholines in the preventive treatment of protozoal diseases
PCT/EP2003/000072 WO2003061669A1 (en) 2002-01-25 2003-01-07 Use of alkylphosphocholines for the preventative treatment of protozoan diseases

Publications (1)

Publication Number Publication Date
IL162492A0 true IL162492A0 (en) 2005-11-20

Family

ID=7713213

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16249203A IL162492A0 (en) 2002-01-25 2003-01-07 Use of alkylphosphocholines for the preventative treatment of protozoandiseases
IL162492A IL162492A (en) 2002-01-25 2004-06-14 Use of alkylphosphocholines for producing a medicament for the preventative treatment of protozoan diseases

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL162492A IL162492A (en) 2002-01-25 2004-06-14 Use of alkylphosphocholines for producing a medicament for the preventative treatment of protozoan diseases

Country Status (16)

Country Link
EP (1) EP1467742A1 (en)
JP (1) JP2005515244A (en)
CN (1) CN1622811A (en)
AR (1) AR038224A1 (en)
AU (1) AU2003236787B2 (en)
BR (1) BR0307021A (en)
CA (1) CA2470185A1 (en)
CO (1) CO5601024A2 (en)
DE (1) DE10203195A1 (en)
IL (2) IL162492A0 (en)
MX (1) MXPA04007193A (en)
NZ (1) NZ548040A (en)
PE (1) PE20030732A1 (en)
TW (1) TWI339582B (en)
WO (1) WO2003061669A1 (en)
ZA (1) ZA200404690B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT501545B1 (en) * 2005-02-23 2007-10-15 Obwaller Andreas Dr CLEANING AGENT FOR CONTACT LENSES
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
JP5232009B2 (en) * 2005-12-19 2013-07-10 エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング Alkyl phospholipid derivatives having reduced cytotoxicity and uses thereof
CN104473941A (en) * 2014-12-20 2015-04-01 长沙佰顺生物科技有限公司 Miltefosine-containing medicine preparation and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132344A1 (en) * 1991-09-27 1993-04-01 Max Planck Gesellschaft METHOD FOR PRODUCING A MEDAL FOR ORAL OR TOPICAL ADMINISTRATION IN THE TREATMENT OF LEISHMANIASIS
DE4132345A1 (en) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Medicament compsns. for intravenous admin. of lytic agents - used for treatment of tumours, auto-immune disorders, multiple sclerosis, etc.
DK0634927T3 (en) * 1992-03-06 2001-10-29 Lica Pharmaceuticals As Treatment and prophylaxis of diseases caused by parasites or bacteria
DE69804865T2 (en) * 1998-01-22 2002-11-07 Zentaris Ag SOLID MILTEFOSIN CONTAINING MEDICINES FOR ORAL ADMINISTRATION IN THE TREATMENT OF LEISHMANIASIS
DE10020812C2 (en) * 2000-04-20 2003-06-26 Robert Koch Inst Use of naphthindazole-4,9-quinones as antiparasitic agents
WO2002036588A2 (en) * 2000-11-06 2002-05-10 U.S. Army Medical Research And Materiel Command Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis

Also Published As

Publication number Publication date
TW200302103A (en) 2003-08-01
NZ548040A (en) 2007-06-29
TWI339582B (en) 2011-04-01
MXPA04007193A (en) 2004-10-29
JP2005515244A (en) 2005-05-26
EP1467742A1 (en) 2004-10-20
BR0307021A (en) 2004-11-03
AU2003236787B2 (en) 2007-03-22
CO5601024A2 (en) 2006-01-31
AR038224A1 (en) 2005-01-05
WO2003061669A1 (en) 2003-07-31
IL162492A (en) 2009-12-24
CA2470185A1 (en) 2003-07-31
PE20030732A1 (en) 2003-09-27
CN1622811A (en) 2005-06-01
DE10203195A1 (en) 2003-08-07
ZA200404690B (en) 2004-09-27

Similar Documents

Publication Publication Date Title
HK1249850A1 (en) Method for the treatment of multiple sclerosis
HUS2200036I1 (en) Use of dihydroimidazolones for the treatment of dogs
AU2002342613A8 (en) Treatment for wounds
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
GB2418025B (en) Device for the prevention or treatment of ulcers
GB0201674D0 (en) Medical treatment
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
AP2005003336A0 (en) Combination for the treatment of ADHD
PL377464A1 (en) Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
GB0218879D0 (en) Medical treatment
GB0223570D0 (en) Surface treatment
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
HUP0500199A3 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
IL162492A0 (en) Use of alkylphosphocholines for the preventative treatment of protozoandiseases
AU2003296545A8 (en) Use of a trpm8-activating substance for the treatment of tumours
GB2388027B (en) Use of palatinose for the treatment of mental stress
AU2003268939A1 (en) Bisphosphonates for the treatment of antheroscleorosis and devices comprising them
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
AU2003236787A1 (en) Use of alkylphosphocholines for the preventative treatment of protozoan diseases
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
GB0227410D0 (en) Slip preventative treatment for floors
GB0220820D0 (en) Treatment
GB0220913D0 (en) Medical treatment
GB0220912D0 (en) Medical treatment
GB0220849D0 (en) Medical treatment